Cases 31 - 40 of 220
Vertex Pharmaceuticals Incorporated v. Lupin Limited et al
as 1:2022cv00966
Plaintiff:
Vertex Pharmaceuticals Incorporated
Defendant:
Lupin Limited and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Avion Pharmaceuticals, LLC et al v. Lupin Limited et al
as 1:2022cv00729
Counter Defendant:
Avion Pharmaceuticals, LLC and Albion Laboratories, Inc.
Counter Claimant:
Lupin Limited and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Neurocrine Biosciences, Inc. v. Lupin Limited et al
as 1:2022cv00639
Plaintiff:
Neurocrine Biosciences, Inc.
Defendant:
Lupin Limited, Lupin Pharmaceuticals, Inc. and Lupin Inc.
Counter Claimant:
Lupin Atlantis Holdings S.A.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Aragon Pharmaceuticals, Inc. et al v. Lupin Limited et al
as 1:2022cv00637
Plaintiff:
Aragon Pharmaceuticals, Inc., Janssen Biotech, Inc. and Sloan Kettering Institute for Cancer Research
Defendant:
Lupin Limited and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ARAGON PHARMACEUTICALS, INC. et al v. LUPIN LIMITED et al
as 2:2022cv02825
Plaintiff:
ARAGON PHARMACEUTICALS, INC., JANSSEN BIOTECH, INC. and SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH
Defendant:
LUPIN LIMITED and LUPIN PHARMACEUTICALS, INC.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
JAZZ PHARMACEUTICALS IRELAND LIMITED v. LUPIN LTD. et al
as 2:2022cv02773
Plaintiff:
JAZZ PHARMACEUTICALS IRELAND LIMITED
Defendant:
LUPIN LTD., LUPIN INC. and LUPIN PHARMACEUTICALS, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Exeltis USA, Inc. et al v. Lupin Ltd. et al
as 1:2022cv00434
Counter Defendant:
Exeltis USA, Inc., Laboratorios Leon Farma, S.A., Chemo Iberica, S.A. and others
Counter Claimant:
Lupin Ltd. and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
BAUSCH & LOMB, INC. et al v. LUPIN LTD.
as 3:2022cv00534
Plaintiff:
BAUSCH & LOMB, INC., BAUSCH & LOMB IRELAND LIMITED and EYE THERAPIES, LLC
Defendant:
LUPIN LTD., LUPIN ATLANTIS HOLDINGS SA, LUPIN INC. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
as 1:2021md03017
In Re:
Xarelto (Rivaroxaban) ('310) Patent Litigation
Not Classified By Court:
Clerk of MDL Panel, Lupin Limited, Lupin Pharmaceuticals, Inc. and others
Counter Defendant:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
TARO PHARMACEUTICALS U.S.A., INC. et al v. LUPIN LIMITED et al
as 1:2021cv20320
Plaintiff:
TARO PHARMACEUTICALS U.S.A., INC. and TARO PHARMACEUTICALS NORTH AMERICA, INC.
Defendant:
LUPIN LIMITED, LUPIN PHARMACEUTICALS, INC. and LUPIN ATLANTIS HOLDING SA
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
